DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
down	ITM2A; IGKV6D-21; IGLV3-12; IGKV1D-33; IGKV2D-24; TRAV2; IGLV3-21; IGKV3-11; IGLV7-46; IGLV5-45; IGKV2-28; IGLV4-60; IGLV3-19; IGLV9-49; IGKV2D-28; IGLV2-14; IGKV6-21; IGKV1-33; IGKV1-39; IGLV5-37; IGKV1D-39; TRDV2; VPREB3; IGKV2D-40; IGKV3-7; IGKV1-9; IGKV2D-29; IGLV4-3; IGKV1D-13; IGLV4-69; IGLV2-23; IGKV1D-16; IGKV2D-30; IGKV3-20; IGKV2-24; IGLV2-8; IGKV1-8; IGKV4-1; IGKV1-16; IGKV1D-17; TRAV14DV4; IGLV3-16; IGLV6-57; IGLV2-11; IGKV3D-11; TRDV1; IGKV1-27; IGKV1-6; IGKV1-12; IGKV3D-15; IGKV5-2; IGKV1-17; IGLV1-40; TRAV38-2DV8; IGKV1D-12; IGLV3-1; IGLV1-44; IGKV3D-20; TRAV18; IGKV1-5; IGLV3-25; IGKV1-13; IGLV8-61; IGLV2-18; IGLV1-36; IGLV7-43; IGLV3-9; IGLV3-27; TRAV40; IGLV1-51; IGKV2-30; TRAV38-1; IGKV2-29; TRDV3; TRAV9-2; TRAV19; IGLV1-47; IGKV3-15; IGLV3-10; IGKV1D-43; IGLV5-48; IGLV10-54;	GO:0002377~immunoglobulin production	82	107	76.6355140186916	0	0	0	0	0	0	0
down	IGKV2-28; IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; HP; JCHAIN; IGKV1D-33; IGKV1-33; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV2D-28; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHA2; HPX; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; ADRB2; IGLC6; IGLC2; IGLC3; FOLR2; IGHV1-2; FCGR2B; HBA1; IGLV3-21; LDLRAP1; TMEM108; CLEC9A; FCGR1B; SCGB3A2; STAB1; MARCO;	GO:0006898~receptor-mediated endocytosis	73	160	45.625	0	0	0	0	0	0	0
down	IGHV3-11; IGHV4-39; IGHV3-74; IGHV1-69; IGLL5; IGHG2; IGHV3-30; IGHV1-2; IGHV4-4; IGHV3-43; IGHV4-28; TRDC; IGLC6; IGHV3OR16-13; IGHV1-46; IGHV3-64; IGHV3-66; IGHV3-72; TRBC2; IGHA2; IGHV1-3; IGHV1-18; IGHV3-15; IGHV3-49; IGHV1-69-2; IGHV3-20; IGHV3-21; IGLC7; IGLC3; IGHV3-23; IGHV3-13; IGHV2-70; IGHV3-53; IGHV3-7; IGHV1-58; IGHV4-61; IGHV2-5; IGHD; IGHV2-26; TRBC1; IGHV5-51; IGHV3-73; IGLC2; IGKC; IGHV6-1; IGHV4-31; IGHV3-48; IGHV1-24; IGHV4-59; IGHV4-34; IGHV3-33;	GO:0006910~phagocytosis, recognition	51	99	51.5151515151515	0	0	0	0	0	0	0
down	FCER1G; FCGR2B; ARHGAP25; AIF1; BIN2; MARCO; IGHV3-66; IGHG2; IGHV1-2; IGHV3-33; IGHV3-30; IGHV2-26; IGLC2; IGHV3-53; IGHV1-24; IGHV3-7; IGHV3-72; IGHA2; IGHV3-43; IGHV3-20; IGHV3-74; IGHV3-21; IGHV2-5; TRDC; IGHV1-69; TRBC2; IGHV3-11; IGLC7; IGHV4-39; IGHV4-4; IGHV3-49; IGHV1-3; IGHV1-46; IGHV4-59; IGHV4-28; IGHV3-64; IGHV4-61; IGLC6; IGHV3-73; IGHV3-15; IGHV1-69-2; IGHV6-1; IGHV3-13; IGHV3-48; IGHV2-70; IGKC; IGHV4-34; IGHV3OR16-13; IGLC3; IGHV5-51; IGHV1-58; IGHV1-18; IGHD; IGLL5; TRBC1; IGHV3-23; IGHV4-31;	GO:0006911~phagocytosis, engulfment	57	115	49.5652173913044	0	0	0	0	0	0	0
down	IGKV2-28; IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; FCN1; FCN3; IGKV1D-33; IGKV1-33; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV2D-28; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; C2; C4A; C4B; IGLC6; IGLC2; IGLC3; IGHV1-2; IGLV3-21; RGCC;	GO:0006956~complement activation	65	92	70.6521739130435	0	0	0	0	0	0	0
down	IGKV2-28; IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; IGKV1D-33; IGKV1-33; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV2D-28; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; C4BPA; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; C2; C4A; C4B; IGLC6; IGLC2; IGLC3; IGHV1-2; IGLV3-21; IGHV1-18; TRDC; IGHV3OR16-13; IGHV4-4; IGHV3-21; IGHV5-51; IGHV3-20; IGHD; IGHV1-24; IGHV1-69-2; IGHV3-49; IGHV4-61; IGHV4-31; TRBC2; IGLL5; IGHV4-28; IGHV2-26; IGHV3-15; TRBC1; IGHV6-1; IGHV3-74; IGHV3-64; IGHV1-3; IGHV3-66; IGHV3-72; IGHA2; IGHV1-58; IGHV3-43; IGHV3-73;	GO:0006958~complement activation, classical pathway	92	161	57.1428571428571	0	0	0	0	0	0	0
down	SIRPB1; TNFRSF13B; DOK2; LILRA1; GLP2R; IGSF6; PRL; IFNG; IL2RA; CD3D; GP1BA; ADRB2; CD3E; CD3G; IFITM1; LAG3; CXCR1; CXCR2; KLRC1; CD27; CDA; VIPR2; IFNAR2; CXCR3; CCR5; GEM; KLRB1; ADGRE1; PTK2B; DTX1; LILRB2; KLRG1; ADGRG7; MYD88; BAG1; ADGRE3; ADGRL3; KLRF1; CLEC1B; MARCO; CLEC4A; CYSLTR1; LY96; TRBV24-1; TRBV6-4; TRBV19; TRBV6-6; TRBV5-1; CD80; TRBV6-1; TRBV7-1; TRBV27; TRBV7-3; TRBV6-8; TRBV17; TRBV5-5; TRBV3-1; TRBV2; TRBV13; TRBV28; TRBV6-2; TRBV11-1; TRBV25-1; TRBV7-2; TRBV4-1; TRBV11-3; TRBV7-6; TRBV29-1; TRBV10-1; TRBV7-7; TRBV14; TRBV15; TRBV5-7; TRBV30; TRBV10-2; TRBV6-7; TRBV4-2; TRBV20-1; TRBV7-4; TRBV12-5; TRBV6-5; TRBV12-4; TRBV5-6; TRBV16; TRBV23-1; TRBV5-4; TRBV9; TRBV5-3; TRBV12-3; TRBV18; TRBV7-9; TRBV11-2; TRBV10-3;	GO:0007166~cell surface receptor signaling pathway	93	268	34.7014925373134	0	0	0	0	0	0	0
down	IGKV2-28; IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; IGKV1D-33; IGKV1-33; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV2D-28; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; C4BPA; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; C2; C4A; C4B; IGLC6; IGLC2; IGLC3; CD19; IGHV1-2; IGLV3-21; CR1L;	GO:0030449~regulation of complement activation	65	113	57.5221238938053	0	0	0	0	0	0	0
down	IGKV2-28; IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; IGKV1D-33; IGKV1-33; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV2D-28; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; IGLC6; IGLC2; IGLC3; IGHV1-2; PSMB8; PSMB9; FCER1G; PSMB10; LILRA4; IGLV3-21; NFATC3; PSMA8; PSMF1; LAT2;	GO:0038095~Fc-epsilon receptor signaling pathway	67	171	39.1812865497076	0	0	0	0	0	0	0
down	IGKV2-28; IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; ARPC1B; IGKV1D-33; IGKV1-33; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV2D-28; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; CD3G; FGR; IGLC6; IGLC2; IGLC3; FCGR2A; CD247; IGHV1-2; FCGR2B; NCKAP1L; ACTB; IGLV3-21; CYFIP2;	GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis	68	135	50.3703703703704	0	0	0	0	0	0	0
down	HP; PPBP; ELANE; IL10; GNLY; CAMP; CXCL6; S100A12; IRF8; CEBPE; LYG2; NR1H4; MYD88; TLR9; STAB1; SLAMF8; IGHV3-48; IGHV6-1; IGHG2; IGLC3; IGHV1-46; IGHV3-53; IGHV3-13; IGLC6; IGHV1-24; TRBC1; IGHV3-73; IGHV1-2; TRBC2; IGHV3-30; IGHA2; IGLC2; IGHV3-72; IGLL5; IGHV2-5; IGHD; IGHV3-49; IGHV3OR16-13; IGHV3-74; IGHV1-18; IGHV2-70; IGHV3-7; IGHV1-58; IGHV4-34; IGHV3-15; IGHV5-51; IGHV3-66; IGHV3-64; IGHV3-23; FCER1G; IGHV1-69; IGHV1-69-2; IGHV4-31; IGLC7; TRDC; IGHV3-20; IGHV4-61; IGHV3-43; IGKC; IGHV4-39; IGHV4-28; IGHV2-26; IGHV4-4; MPO; IGHV3-21; IGHV3-11; IGHV4-59; IGHV1-3; IGHV3-33;	GO:0042742~defense response to bacterium	69	216	31.9444444444444	0	0	0	0	0	0	0
down	PRKCB; MS4A1; CD19; CTLA4; PTPN6; MNDA; NCKAP1L; LAT2; IGHV4-34; IGHV4-4; IGHV4-61; IGHV3-33; IGHV3-11; IGHV3-72; IGHV3-21; IGHV4-28; IGHV4-39; IGHV1-69-2; IGHV1-2; IGHV2-70; IGHV2-5; IGHV2-26; IGLL5; IGLC3; IGHV3-43; IGHV3-30; IGHV3-13; TRBC2; IGHV5-51; CD79B; IGHG2; IGHV3-23; IGHV1-3; IGHV1-69; IGHV3-73; IGHV1-46; IGLC6; IGHV4-59; IGHV3-64; IGHV6-1; IGHV1-18; LCK; IGHV1-24; IGLC7; TRBC1; IGHA2; IGHV3-74; IGHV3-20; TRDC; IGHD; IGHV3-15; IGHV3-66; IGHV3-48; IGLC2; IGHV4-31; IGHV3OR16-13; IGHV1-58; IGHV3-53; IGHV3-49; IGHV3-7; IGKC;	GO:0050853~B cell receptor signaling pathway	61	125	48.8	0	0	0	0	0	0	0
down	TLR9; IGHV2-26; IGHV3-53; IGHV3-49; IGHV1-69-2; IGLC7; IGLC3; IGHV3-15; IGHV4-39; IGHV3-64; IGHV4-28; IGHV2-70; IGHV3-21; IGHD; IGHV4-59; IGHV1-69; IGHV4-4; IGHV3-73; IGHV3-23; IGHV3-13; IGHV1-2; TRBC1; IGHV1-18; IGLL5; IGHV1-24; IGHV3-72; IGHV3-74; IGHV3-48; IGHV3-11; TRBC2; IGHG2; IGHV3-33; IGLC2; IGHV3-20; IGHV1-46; IGLC6; IGHV4-31; IGHV5-51; IGHV4-61; IGHV1-3; IGHV3OR16-13; IGHV6-1; IGHV4-34; IGHV3-66; IGHV1-58; IGHV3-7; IGHA2; TRDC; IGKC; IGHV3-30; IGHV3-43; IGHV2-5;	GO:0050871~positive regulation of B cell activation	52	98	53.0612244897959	0	0	0	0	0	0	0
up	UGT1A9; UGT1A1; UGT1A3; UGT1A7; UGT1A8; UGT1A10; UGT1A6;	GO:0052697~xenobiotic glucuronidation	7	9	77.7777777777778	0.00010711823435172	0.0213839296043051	0.381448032526482	0.383054806041757	0.380591086651668	0.381448032526482	0.187309443865361
up	FXYD1; GABRP; CLDN4; SLC26A4; GABRR1; GABRA2; GLRB; CLCNKB; CLDN17; FXYD3; ANO4; ANO1; SLC26A9; SLC26A10; ANO3; ANO2; GABRQ; CLCA2; GABRA3; GABRA4; GABRA5; GABRE;	GO:1902476~chloride transmembrane transport	22	97	22.680412371134	0.00012660464410707	0.0238283267014159	0.450459323732975	0.452738207326902	0.449699695868333	0.450459323732975	0.208720787304957
down	F2RL2; PF4; PRKCB; LCK; GP1BA; PF4V1; GP9; PTPN6; CD40LG; FCER1G; GP5; P2RX1; DGKK; PIK3R6; ADAMTS13; TREML1; PIK3R5; F2RL3; GP6; CLEC1B;	GO:0030168~platelet activation	20	102	19.6078431372549	0.00015687254683294	0.0159262985641825	0.662472765275516	0.668904539695666	0.613057913023139	0.662472765275516	0.142306190054907
down	ADCY5; S1PR4; CCL1; CD52; AVPR1A; PTK2B; CHRNA10; PROK2; CYSLTR1; PTGDR; CCR10; TBXA2R; CXCR2; CXCR3; CCR7; CCR8; PTGER2; CCR6; CCR5; FPR1; CXCR5; PTGIR; CCR2; CXCR1; CX3CR1;	GO:0007204~positive regulation of cytosolic calcium ion concentration	25	150	16.6666666666667	0.00024721683531681	0.0239575587679745	1	1	0.760450918322244	0.999962599350624	0.214067876320889
down	ACOD1; SLC2A4; YBX3; CRHBP; PCK1; TCL1A; ADAMTS13; NKX3-1; OCSTAMP; INPP5K; DCSTAMP; PYCARD; KLF2; XCL2; CCL1; CCL23; CCL8; CX3CL1; CCL21; CCL7; CCL19; XCL1;	GO:0071356~cellular response to tumor necrosis factor	22	125	17.6	0.00029240823271947	0.0277073045403522	1	1	0.811552806320374	0.999962599350624	0.24757296429793
up	CLDN4; CLDN7; CLDN14; CLDN6; CLDN8; CLDN17; CLDN18; CLDN10; CLDN16;	GO:0016338~calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules	9	21	42.8571428571429	0.00033724323229944	0.057427704700134	1	1	0.92876786175267	0.99999999976568	0.503029687662302
up	CYP1A1; CYP2C9; CYP2C19; CYP2J2; CYP4A11; CYP2E1; CYP2S1; CYP2F1; CYP2C18;	GO:0019373~epoxygenase P450 pathway	9	21	42.8571428571429	0.00033724323229944	0.057427704700134	1	1	0.92876786175267	0.99999999976568	0.503029687662302
down	IFNG; HLA-G; IL12B; CD40LG; CCR7; IRF8; SCIMP; CCL19; TLR9;	GO:0032735~positive regulation of interleukin-12 production	9	26	34.6153846153846	0.0003600376260735	0.0326638390973921	1	1	0.868585651343533	0.999962599350624	0.291861067138984
down	CCL21; RAC2; LBP; CXCR2; CCR7; XCL1; NCKAP1L; MOSPD2; CCL19;	GO:0090023~positive regulation of neutrophil chemotaxis	9	26	34.6153846153846	0.0003600376260735	0.0326638390973921	1	1	0.868585651343533	0.999962599350624	0.291861067138984
down	CCL21; TNFSF11; FGF17; F10; EGF; LCK; CSF3; OSM; HCLS1; RAC2; CD19; FGFR4; FGF9; CCR7; CD80; CX3CR1; ADAM8; CX3CL1; RHOG; ILK; TRAT1; PIK3R5; CCL19; P2RY12; KL; ICOS;	GO:0051897~positive regulation of protein kinase B signaling	26	165	15.7575757575758	0.00040583566933483	0.035315985592729	1	1	0.893547140666111	0.999962599350624	0.315558780810361
up	CA2; KRT6A; KRT16; SERPINB5; RIPK4; TBX4; CA9; TBX5;	GO:0002009~morphogenesis of an epithelium	8	17	47.0588235294118	0.00044299206844511	0.0688756363808577	1	1	0.99999999976568	0.99999999976568	0.603306192318084
down	TYROBP; CTLA4; IL10; FCGR2B; MNDA; CD300A; TNFRSF13B;	GO:0030889~negative regulation of B cell proliferation	7	16	43.75	0.00053749904627886	0.0435924908139594	1	1	0.947449898859677	0.999962599350624	0.389511803871956
down	DLL1; CHP2; FGF17; GLP2R; EGF; IFNG; WNT1; GNAI2; IL4; BMP4; IL7; OSM; FOLR2; HCLS1; RAC2; BMP5; FGFR4; CXCR2; HTR2A; PTPN6; AVPR2; FGF9; DRD3; FLT3; AVPR1A; MATK; FASLG; PGF; AIF1; TCL1A; CX3CL1; RHOG; BCL2L1; BST1; SLAMF1; MAB21L1; ILK; PTK2B; HLX; NTRK3; FXN; AKIRIN2; EAPP; TET1; HPSE2; ST8SIA1; CDX2; NKX3-1; SIRPG; CLEC11A; REG1A; PDGFD; REG3A; PRL; REG1B; CSF3; PROK2;	GO:0008284~positive regulation of cell population proliferation	57	490	11.6326530612245	0.00055624161993039	0.0435924908139594	1	1	0.952285653320841	0.999962599350624	0.389511803871956
down	ELANE; ALOX5; CCR6; ADAM8; CX3CL1; FUT7;	GO:0002523~leukocyte migration involved in inflammatory response	6	11	54.5454545454545	0.00055750125345932	0.0435924908139594	1	1	0.952586362382275	0.999962599350624	0.389511803871956
down	MPO; DEFA4; GNLY; DEFA3; S100A12; DEFA5; DEFA6; COTL1; CLEC6A;	GO:0050832~defense response to fungus	9	28	32.1428571428571	0.00056228588057405	0.0435924908139594	1	1	0.953780114552805	0.999962599350624	0.389511803871956
down	TNFSF11; FOXO3; F13A1; POMC; IL2RA; PF4; MMP1; IL4; FCER2; ALOX5; CSF3; UBB; IL7; OSM; LBP; FPR1; IL10; PTPN6; IL12B; IL2RG; CD80; FLT3; CCR2; FASLG; CEBPD; CCR5; CX3CL1; IL5RA; BCL2L1; IL10RB; IL16; IRF4; BATF; IFNL1; CCL19; GREM2; IFNAR2;	GO:0019221~cytokine-mediated signaling pathway	37	278	13.3093525179856	0.0005746823322883	0.0437579547299521	1	1	0.956958087861291	0.999962599350624	0.390990272919964
up	FBN2; ALDH1A3; MFAP2; FOXL2; EFEMP1; VAX2;	GO:0048048~embryonic eye morphogenesis	6	9	66.6666666666667	0.00060937199109645	0.0907964266733714	1	1	0.99999999976568	0.99999999976568	0.795318189867557
up	DAPL1; SRRM4; SPATA31C2; SOX15; ZIC2; KRT6A; INHA; FGF1; MGP; ROS1; PMCH; COL15A1; FOXL2; TPPP2; KRTDAP; BNC1; NHLH2; MECOM; SIM2; ANGPT1; INA; ODF4; ZNF750; SLC9C1; SFRP4; CXCL17; CHRDL2; SPATA31E1; SCX; SPATA19; NPAS4; EGFL6; OSR1; ACER1; TWIST2; TCP11; ATOH8; RBM24; THEG; SPIC; POU6F2; SOX17; NKX2-8; NR2F2; HES5; NR2F1; POU2F3; FOXA1; SPINK6; EYA4; SOX1; FOXI2; NKX6-1; CCDC160; FOXC2; EGFR; NKX3-2; FOXQ1; FOXD4L5; SRY; ELF5; SOX2; EHF; DLX5; HES2; NKX1-2; SOX21; SPINK5; ID4; SRMS; FOXD4L4; DLX3; FOXE1; HEY2;	GO:0030154~cell differentiation	74	572	12.9370629370629	0.00064344138129224	0.0920378551800423	1	1	0.99999999976568	0.99999999976568	0.806192303628964
down	CCL21; CCR7; CXCL12; LILRB1; CCL19;	GO:2000669~negative regulation of dendritic cell apoptotic process	5	7	71.4285714285714	0.00068625008149769	0.0501365974887203	1	1	0.974752647231223	0.999962599350624	0.447985333326721
down	ARHGAP6; FAM107A; VIL1; HCLS1; AIF1; CORO7; LMOD2; CATIP; MSRB1;	GO:0030041~actin filament polymerization	9	29	31.0344827586207	0.0006937287175972	0.0501365974887203	1	1	0.975503263617744	0.999962599350624	0.447985333326721
up	UGT1A9; UGT1A6; UGT1A1; UGT1A4; UGT1A3; UGT1A7; UGT1A10;	GO:0052695~cellular glucuronidation	7	14	50	0.00076843869506193	0.101775436057092	1	1	0.99999999976568	0.99999999976568	0.891487237367752
down	TRPM2; IL4; GATA1; FLT3; LILRB1; BATF3;	GO:0097028~dendritic cell differentiation	6	12	50	0.00078941037591873	0.0561007640486245	1	1	0.985244822727454	0.999962599350624	0.501276926258529
down	TRAV19; TRBV12-3; TRAV8-4; TRAC; TRBC1; HLA-DQA2; CD3D; TRBV7-9; TRAV29DV5; LCK; CD3E; CD3G; CD247; PSMB8; PSMB9; PSMB10; TRAT1; SKAP1; PSMA8; PSMF1; BTNL3; HHLA2; BTNL10; CTLA4; BTN1A1; BTNL8;	GO:0050852~T cell receptor signaling pathway	26	174	14.9425287356322	0.00082017606582796	0.057331651552302	1	1	0.988378694892202	0.999962599350624	0.512275270307439
up	UGT1A9; UGT1A1; UGT1A7; UGT1A10; UGT1A8;	GO:0051552~flavone metabolic process	5	6	83.3333333333333	0.0008962901710765	0.107228339508103	1	1	0.99999999976568	0.99999999976568	0.93925115783328
up	CYP1A1; CYP2E1; ADH1A; CYP2C9; UGT1A1; CYP2C19; FMO1; FMO2; UGT1A7;	GO:0017144~drug metabolic process	9	25	36	0.00092955216016532	0.107228339508103	1	1	0.99999999976568	0.99999999976568	0.93925115783328
up	CYP2C9; CYP4B1; CYP2C19; CYP2W1; CYP2F1; CYP2J2; CYP2C18; CYP2S1; CYP2E1;	GO:0042738~exogenous drug catabolic process	9	25	36	0.00092955216016532	0.107228339508103	1	1	0.99999999976568	0.99999999976568	0.93925115783328
down	PF4; ARG1; IL10; IL12B; IRF8; IRF4; BATF; MYD88;	GO:0042832~defense response to protozoan	8	24	33.3333333333333	0.00093249726467681	0.0641317473642247	1	1	0.997116218781989	0.999962599350624	0.573036138446589
down	LTF; DEFA5; DEFA4; DEFA6; DEFA3;	GO:0051673~membrane disruption in other organism	5	8	62.5	0.00105426456825464	0.0712928868488475	1	1	0.999962599350624	0.999962599350624	0.637023038629428
up	FXYD1; KCNK3; CASQ2; ATP6V1B1; ATP4A; GRIA1; ATP4B; SCNN1B; SCNN1G; CLCNKB; ATP12A; FXYD3; ANO4; ATP13A5; ATP13A4; ANO1; NALCN; ANO3; ATP6V0A4; ANO2; ASIC5; CLCA2; GABRR1; GABRA3; GABRA5; GABRP; GABRA2; GABRQ; GLRB; GABRE; GABRA4; HTR3B; CHRNB4;	GO:0034220~ion transmembrane transport	33	208	15.8653846153846	0.00118804600948896	0.132764141560392	1	1	0.99999999976568	0.99999999976568	1
down	LTF; RNASE3; CAMP; DEFA3; DEFA5; DEFA6; DEFA4;	GO:0002227~innate immune response in mucosa	7	19	36.8421052631579	0.00120949332077203	0.0793427618426449	1	1	0.999962599350624	0.999962599350624	0.708951053551982
down	CCL7; CCL1; CX3CL1; CCL23; XCL1; XCL2; CCL8;	GO:0048245~eosinophil chemotaxis	7	20	35	0.00154001348861077	0.0968470317373044	1	1	0.999962599350624	0.999962599350624	0.865356884345828
down	NOS1AP; KCNQ1; SCN1B; SCN4B; KCNE5; KCNE1B; KCNE4;	GO:0060307~regulation of ventricular cardiac muscle cell membrane repolarization	7	20	35	0.00154001348861077	0.0968470317373044	1	1	0.999962599350624	0.999962599350624	0.865356884345828
up	CIDEA; DRD2; EDN2; DRD1; ACADL; ADORA1; NMU; ADRB3;	GO:0001659~temperature homeostasis	8	22	36.3636363636364	0.00168610223975407	0.182712169980623	1	1	0.99999999976568	0.99999999976568	1
down	CCL21; CD3E; CCR7; CX3CL1; ILK; PTK2B; SKAP1; NINJ1;	GO:0001954~positive regulation of cell-matrix adhesion	8	27	29.6296296296296	0.00174619313377811	0.104869965104646	1	1	0.999962599350624	0.999962599350624	0.937044167864321
up	SHANK2; ADRA1D; ADRB3; DRD1; DRD2; ADRA1B; SHANK1; PMCHL2; PMCH;	GO:0007610~behavior	9	28	32.1428571428571	0.00178149122863769	0.187370959812011	1	1	0.99999999976568	0.99999999976568	1
down	PGLYRP1; LTF; SEMG1; DEFA4; GNLY; DEFA3; S100A12; DEFA5; DEFA6;	GO:0031640~killing of cells of other organism	9	35	25.7142857142857	0.00210444946195398	0.118717463698705	1	1	0.999962599350624	0.999962599350624	1
down	MPO; HBA1; HBG2; HBZ; HBD; HBQ1; HBM; HBG1;	GO:0042744~hydrogen peroxide catabolic process	8	28	28.5714285714286	0.00211597730795066	0.118717463698705	1	1	0.999962599350624	0.999962599350624	1
down	TNFSF14; CORO1A; NCKAP1L; SLC39A3; GPR174; SLC46A2; SIT1; PPP2R3C;	GO:0043029~T cell homeostasis	8	28	28.5714285714286	0.00211597730795066	0.118717463698705	1	1	0.999962599350624	0.999962599350624	1
down	ZG16; IL18RAP; EOMES; AVPR2; LILRB1;	GO:0032609~interferon-gamma production	5	10	50	0.00219933557476693	0.120230344753925	1	1	0.999962599350624	0.999962599350624	1
down	HLA-E; HLA-G; CLEC12B; LILRB1; KIR2DL4;	GO:0045953~negative regulation of natural killer cell mediated cytotoxicity	5	10	50	0.00219933557476693	0.120230344753925	1	1	0.999962599350624	0.999962599350624	1
up	CES2; HPGDS; GSTA1; ATP6V1B1; HPGD; CYP4F8; CYP2S1;	GO:0006693~prostaglandin metabolic process	7	18	38.8888888888889	0.00240814146635537	0.2392087189913	1	1	0.99999999976568	0.99999999976568	1
down	LILRA5; IFNG; ORM1; LPL; ORM2; MMP8; LILRA2;	GO:1904469~positive regulation of tumor necrosis factor secretion	7	22	31.8181818181818	0.00240828525118975	0.128361603888413	1	1	0.999962599350624	0.999962599350624	1
down	LILRA5; IFNG; MBP; LPL; AIF1; IL16; LILRA2; TLR8; PYCARD;	GO:2000778~positive regulation of interleukin-6 secretion	9	37	24.3243243243243	0.00290167263397023	0.149442099114032	1	1	0.999962599350624	0.999962599350624	1
up	COL6A5; CHL1; EFS; CNTN5; ITGBL1; AMBP; ITGB6; CD9; CDH3; ANOS1; LAMA1; COL8A1; COL15A1; ATP4B; SLURP1; CDH6; CDH8; CDH11; CDH15; RND3; CLDN10; CNTN1; MSLN; PKP1; LY6D; HABP2; DSC3; POSTN; CDSN; FLG2; HES5; GRHL2; AMTN; EGFL6; IZUMO1; SPACA4; CNTNAP3B; MAGI1; COL12A1; OMD; NTM; CLCA2; PCDH1; CDH16; PCDHAC1; PCDHA7; PCDHB13; SIGLEC6; PCDH7; PCDHA5; PCDHB10; PCDHB1; PCDHGB4; PCDHGA3; PCDHGC4; PCDHGA8; PCDHB6; PCDHA6;	GO:0007155~cell adhesion	58	454	12.7753303964758	0.00293073144069522	0.271216607816821	1	1	0.99999999976568	0.99999999976568	1
down	C2; C4A; C4B; CD300LF;	GO:2000427~positive regulation of apoptotic cell clearance	4	6	66.6666666666667	0.00294398131462914	0.149442099114032	1	1	0.999962599350624	0.999962599350624	1
down	HLA-G; FCGR2B; TMEM176B; LILRB1;	GO:2001199~negative regulation of dendritic cell differentiation	4	6	66.6666666666667	0.00294398131462914	0.149442099114032	1	1	0.999962599350624	0.999962599350624	1
up	ERBB3; GATA4; FOXF1; TBX5; RBM24;	GO:0003197~endocardial cushion development	5	9	55.5555555555556	0.00318414412340706	0.284662484632591	1	1	0.99999999976568	0.99999999976568	1
down	TNFSF11; LCK; CCR2; SIRPG; PYCARD; SIRPB1;	GO:0050870~positive regulation of T cell activation	6	17	35.2941176470588	0.00322189760366653	0.157910015885449	1	1	0.999962599350624	0.999962599350624	1
down	BIN1; CACNA1G; SCN2B; KCNQ1; SCN1B; SCN4B; KCNE5; KCNE4; KCNE1B;	GO:0086091~regulation of heart rate by cardiac conduction	9	38	23.6842105263158	0.00338081252564426	0.163815734197126	1	1	0.999962599350624	0.999962599350624	1
up	HPGD; FOXF1; TFAP2B; STRA6;	GO:0097070~ductus arteriosus closure	4	5	80	0.00339640451698631	0.296232745188854	1	1	0.99999999976568	0.99999999976568	1
down	CCL21; FGR; CD19; CCR7; FLT3; PTK2B; CCL19; P2RY12;	GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity	8	31	25.8064516129032	0.00360303486965152	0.170703785379934	1	1	0.999962599350624	0.999962599350624	1
down	DLL1; BMP4; BMP5; HNF4A; INSM1;	GO:0003323~type B pancreatic cell development	5	12	41.6666666666667	0.00405357567573361	0.18021394700141	1	1	0.999962599350624	0.999962599350624	1
down	IL2RA; CTLA4; HLA-G; FCGR2B; FCRLB;	GO:0050777~negative regulation of immune response	5	12	41.6666666666667	0.00405357567573361	0.18021394700141	1	1	0.999962599350624	0.999962599350624	1
down	LPL; MOGAT2; GPAT2; AGMO; MOGAT3; DGAT2;	GO:0019432~triglyceride biosynthetic process	6	18	33.3333333333333	0.00405734965106364	0.18021394700141	1	1	0.999962599350624	0.999962599350624	1
down	IL4; SPI1; IRF4; BATF; DCSTAMP; BATF3;	GO:0043011~myeloid dendritic cell differentiation	6	18	33.3333333333333	0.00405734965106364	0.18021394700141	1	1	0.999962599350624	0.999962599350624	1
down	DLL1; GPR171; HOXB8; HOXA9; ZBTB16; PTK2B;	GO:0045638~negative regulation of myeloid cell differentiation	6	18	33.3333333333333	0.00405734965106364	0.18021394700141	1	1	0.999962599350624	0.999962599350624	1
down	CCL21; GCG; GNAI2; BMP4; PLA2G2A; FGFR4; HTR2A; CCR7; CX3CL1; SLAMF1; PTK2B; SCIMP; NECAB2; GPBAR1; CCL19; GLIPR2; MARCO; PYCARD; GPR55; CCL8; CCL7; CCL1; XCL1; PDGFD; XCL2; CCL23; NTRK3;	GO:0070374~positive regulation of ERK1 and ERK2 cascade	27	209	12.9186602870813	0.00422672354570663	0.185801538132918	1	1	0.999962599350624	0.999962599350624	1
down	SASH3; IL12B; CD40LG; FCER1G; XCL1; TIGIT; TLR9;	GO:0032733~positive regulation of interleukin-10 production	7	25	28	0.00436121765524244	0.186945235503014	1	1	0.999962599350624	0.999962599350624	1
down	FCGR2B; GPS2; FCRL3; CD300A;	GO:0050859~negative regulation of B cell receptor signaling pathway	4	7	57.1428571428571	0.00438426912530521	0.186945235503014	1	1	0.999962599350624	0.999962599350624	1
down	HP; SLC4A1; GZMA; GZMK;	GO:0051354~negative regulation of oxidoreductase activity	4	7	57.1428571428571	0.00438426912530521	0.186945235503014	1	1	0.999962599350624	0.999962599350624	1
up	CYP1A1; CYP2C9; CYP2C19; CYP4A11; CYP4A22;	GO:0097267~omega-hydroxylase P450 pathway	5	10	50	0.00447153018953328	0.371864929250489	1	1	0.99999999976568	0.99999999976568	1
down	FLT3; CXCL6; NKX2-3;	GO:0001776~leukocyte homeostasis	3	3	100	0.00502184809986272	0.199091815928621	1	1	0.999962599350624	0.999962599350624	1
down	HLA-G; LILRB2; LILRB1;	GO:0002767~immune response-inhibiting cell surface receptor signaling pathway	3	3	100	0.00502184809986272	0.199091815928621	1	1	0.999962599350624	0.999962599350624	1
down	MYO7B; ANKS4B; USH1C;	GO:1904970~brush border assembly	3	3	100	0.00502184809986272	0.199091815928621	1	1	0.999962599350624	0.999962599350624	1
down	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.00502184809986272	0.199091815928621	1	1	0.999962599350624	0.999962599350624	1
down	IL2RA; IL4; IL7; CD27; RHOH; PIK3R6;	GO:0045582~positive regulation of T cell differentiation	6	19	31.5789473684211	0.00504266325522773	0.199091815928621	1	1	0.999962599350624	0.999962599350624	1
down	FOXO3; CD160; HLA-G; CD40LG; FASLG; RGCC;	GO:2000353~positive regulation of endothelial cell apoptotic process	6	19	31.5789473684211	0.00504266325522773	0.199091815928621	1	1	0.999962599350624	0.999962599350624	1
up	CORT; KCNK3; CPLX1; GRM6; GALR3; GABBR2; HTR3B; PMCH; SLC6A1; GRIA1; GLRB; NOVA1; SLC18A2; GRIN2A; GRM7; PMCHL2; KCND2; PCDHB10; PCDHB6; PCDHB13; GABRA4; GABRP; GABRQ; GABRE; CHRNB4; CHRM2; PENK; GABRA2; NLGN4Y; NLGN1; HTR1B; GABRA3; GABRR1; GABRA5; HTR1D;	GO:0007268~chemical synaptic transmission	35	249	14.0562248995984	0.00506467894373697	0.395768862779804	1	1	0.99999999976568	0.99999999976568	1
down	F2RL2; SH2B2; F13A1; F10; SERPINA1; HBD; SLC4A1; GP1BA; GP9; GATA1; FCER1G; PRKAR2B; GP5; HNF4A; P2RX1; HBG1; HBG2; NFE2; SCUBE1; CD177; F2RL3; GP6; PROCR;	GO:0007596~blood coagulation	23	171	13.4502923976608	0.00511547427419567	0.200113599130003	1	1	0.999962599350624	0.999962599350624	1
up	OVOL1; GJB3; KRT9; COMP; DHCR24; DACT2; TFAP2B; ABCB6; DSP;	GO:0043588~skin development	9	34	26.4705882352941	0.00528379434773318	0.395768862779804	1	1	0.99999999976568	0.99999999976568	1
down	CD19; CD27; FCGR2B; TLR8; FCER1G;	GO:0016064~immunoglobulin mediated immune response	5	13	38.4615384615385	0.00530902386797549	0.203943043000428	1	1	0.999962599350624	0.999962599350624	1
up	DSP; GRHL1; PKP2; PERP;	GO:0002934~desmosome organization	4	6	66.6666666666667	0.00531233372858797	0.395768862779804	1	1	0.99999999976568	0.99999999976568	1
up	OVOL1; SNAI2; KDF1; OVOL2;	GO:2000647~negative regulation of stem cell proliferation	4	6	66.6666666666667	0.00531233372858797	0.395768862779804	1	1	0.99999999976568	0.99999999976568	1
up	KRT16; KRT3; KRT6C; KRT74; EVPLL; DSP; EVPL;	GO:0045104~intermediate filament cytoskeleton organization	7	22	31.8181818181818	0.0059371155685255	0.424622505460944	1	1	0.99999999976568	0.99999999976568	1
up	GABRR1; GRIA1; FGF14; KCND2; GABRA2; GABRA3; GABRE; GABRA4; GABRA5;	GO:0060078~regulation of postsynaptic membrane potential	9	35	25.7142857142857	0.00619083437391377	0.434086739629718	1	1	0.99999999976568	0.99999999976568	1
down	SCN2B; SCN1B; SCN4B; FXYD6; FXYD5; FXYD2;	GO:2000649~regulation of sodium ion transmembrane transporter activity	6	20	30	0.00619261423553352	0.231119131753734	1	1	0.999962599350624	0.999962599350624	1
down	CD160; HLA-E; HLA-G; KIR2DL4;	GO:0002729~positive regulation of natural killer cell cytokine production	4	8	50	0.00623327864720435	0.231119131753734	1	1	0.999962599350624	0.999962599350624	1
down	FCER1G; FCGR2B; S100A12; RHOH;	GO:0045576~mast cell activation	4	8	50	0.00623327864720435	0.231119131753734	1	1	0.999962599350624	0.999962599350624	1
up	BMPR1B; MATN3; IGF2; AHSG; IGF1; INHA; GLI2; PTHLH; PAX1; BMP7; FGFR3; GJA5; COMP; CDH11; DLX5; PITX1; NKX3-2; TEAD4; EXTL1; TP63; HOXA4; MMP16;	GO:0001501~skeletal system development	22	137	16.0583941605839	0.00632396945844871	0.434894515065627	1	1	0.99999999976568	0.99999999976568	1
down	FCMR; VSTM1; CD300LD; IDO2; CD300LF; CTLA4; IRF8; IRF4;	GO:0002376~immune system process	8	35	22.8571428571429	0.00671018197555717	0.240035501785093	1	1	0.999962599350624	0.999962599350624	1
down	RGS16; RGS14; RGS10; RGS2; GRK6; RGS6; GIT2; RGS18; PHF24;	GO:0008277~regulation of G protein-coupled receptor signaling pathway	9	43	20.9302325581395	0.00677707893868462	0.240035501785093	1	1	0.999962599350624	0.999962599350624	1
down	HBZ; EPB42; TAL1; FAM210B; KLF2;	GO:0043249~erythrocyte maturation	5	14	35.7142857142857	0.00681609678253214	0.240035501785093	1	1	0.999962599350624	0.999962599350624	1
down	IL12B; IL27; TLR9; TLR8; TLR7;	GO:0045078~positive regulation of interferon-gamma biosynthetic process	5	14	35.7142857142857	0.00681609678253214	0.240035501785093	1	1	0.999962599350624	0.999962599350624	1
up	KCNK9; KCNK10; KCNK2; KCNK3; KCNK1; KCNK7;	GO:0030322~stabilization of membrane potential	6	17	35.2941176470588	0.00714716893104961	0.47330140921173	1	1	0.99999999976568	0.99999999976568	1
down	BNIP3L; FCN3; IFNG; RNASE2; PRF1; AZU1; IL12B; IFNAR2; DEFA3; IL10RB; UNC13D; IFNL1; LILRB1; RNASE6; ISG20; APOBEC3G; EXOSC5; TLR8; TLR7; DMBT1; PYCARD; POLR3K; IFITM1; IFIT1B; TLR9;	GO:0051607~defense response to virus	25	198	12.6262626262626	0.00739338806794898	0.252203253773876	1	1	0.999962599350624	0.999962599350624	1
up	CA2; TPD52; CA9; RIMS1;	GO:0046903~secretion	4	7	57.1428571428571	0.00783578719002342	0.473658958199629	1	1	0.99999999976568	0.99999999976568	1
up	FOXP2; ALDH1A3; GLRB; SHANK1;	GO:0060013~righting reflex	4	7	57.1428571428571	0.00783578719002342	0.473658958199629	1	1	0.99999999976568	0.99999999976568	1
up	PGC; KLK7; KLK5;	GO:0002803~positive regulation of antibacterial peptide production	3	3	100	0.00794791579079379	0.473658958199629	1	1	0.99999999976568	0.99999999976568	1
up	SFN; KDF1; TP63;	GO:0010482~regulation of epidermal cell division	3	3	100	0.00794791579079379	0.473658958199629	1	1	0.99999999976568	0.99999999976568	1
up	IRX1; IRX3; HES5;	GO:0072086~specification of loop of Henle identity	3	3	100	0.00794791579079379	0.473658958199629	1	1	0.99999999976568	0.99999999976568	1
up	SLC26A4; ATP6V1B1; ATP12A; ATP6V0A4; RHCG;	GO:0006885~regulation of pH	5	12	41.6666666666667	0.00807975292230911	0.473658958199629	1	1	0.99999999976568	0.99999999976568	1
down	REG3A; REG1A; REG1B;	GO:0044278~cell wall disruption in other organism	3	4	75	0.00835552199828737	0.267618062381728	1	1	0.999962599350624	0.999962599350624	1
down	TLR9; TLR8; TLR7;	GO:0045356~positive regulation of interferon-alpha biosynthetic process	3	4	75	0.00835552199828737	0.267618062381728	1	1	0.999962599350624	0.999962599350624	1
down	FES; HOXA5; CSF3;	GO:0045639~positive regulation of myeloid cell differentiation	3	4	75	0.00835552199828737	0.267618062381728	1	1	0.999962599350624	0.999962599350624	1
down	LY86; SCIMP; CD180; LY96;	GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway	4	9	44.4444444444444	0.00853506268228166	0.267618062381728	1	1	0.999962599350624	0.999962599350624	1
down	BPI; FCGR2B; CD200; VSIG4;	GO:0043031~negative regulation of macrophage activation	4	9	44.4444444444444	0.00853506268228166	0.267618062381728	1	1	0.999962599350624	0.999962599350624	1
down	KCNQ1; KCNE1B; KCNE5; KCNE4;	GO:0086011~membrane repolarization during action potential	4	9	44.4444444444444	0.00853506268228166	0.267618062381728	1	1	0.999962599350624	0.999962599350624	1
down	RBP4; MUC2; TLR9; TFF3; TFF1;	GO:0030277~maintenance of gastrointestinal epithelium	5	15	33.3333333333333	0.00859842273599831	0.267618062381728	1	1	0.999962599350624	0.999962599350624	1
down	APOA2; ELANE; TLR8; TLR7; TLR9;	GO:0045416~positive regulation of interleukin-8 biosynthetic process	5	15	33.3333333333333	0.00859842273599831	0.267618062381728	1	1	0.999962599350624	0.999962599350624	1
down	IFNG; APOA2; AZU1; IL2RG; FCGR2B; PYCARD; FCER1G; SIRPB1; SIRPG;	GO:0050766~positive regulation of phagocytosis	9	45	20	0.00869947739440147	0.268801243548753	1	1	0.999962599350624	0.999962599350624	1
down	IFNG; BMP4; SPI1; CEBPE; NKX2-3; EIF2AK1;	GO:0030225~macrophage differentiation	6	22	27.2727272727273	0.00904514900582609	0.277471333531241	1	1	0.999962599350624	0.999962599350624	1
up	GRXCR2; SRRM4; SLC26A4; SNAI2; CNTN5; GJB6; EYA4; TH; COL11A1; ATP6V1B1; GJB2; GABRA5; GRM7; SIX1; OTOGL; USH1G; ESPNL; MARVELD2; MYO3A; ATP6V0A4; SLC52A3; P2RX2;	GO:0007605~sensory perception of sound	22	143	15.3846153846154	0.00967495732353918	0.549169006174224	1	1	0.99999999976568	0.99999999976568	1
down	IFNG; APOD; IL12B; VIPR2; PTGIR; AIF1; ILK;	GO:0048662~negative regulation of smooth muscle cell proliferation	7	30	23.3333333333333	0.00998626907065536	0.299869375473764	1	1	0.999962599350624	0.999962599350624	1
down	TYROBP; ARG1; APOD; AIF1; MAX; NTRK3; P2RY12;	GO:0048678~response to axon injury	7	30	23.3333333333333	0.00998626907065536	0.299869375473764	1	1	0.999962599350624	0.999962599350624	1
up	GABRA5; GABRA4; GABRA3; GABRA2; GABRE;	GO:0051932~synaptic transmission, GABAergic	5	13	38.4615384615385	0.010478612075595	0.580298853967681	1	1	0.99999999976568	0.99999999976568	1
down	CCL21; TNFSF14; CCR2; XCL1; XCL2;	GO:0010820~positive regulation of T cell chemotaxis	5	16	31.25	0.0106785370075104	0.311871793150852	1	1	0.999962599350624	0.999962599350624	1
down	NR1H4; MYD88; TLR9; TLR8; TLR7;	GO:0034162~toll-like receptor 9 signaling pathway	5	16	31.25	0.0106785370075104	0.311871793150852	1	1	0.999962599350624	0.999962599350624	1
down	TNFSF11; EGF; PRLR; HOXA5; ID2;	GO:0060749~mammary gland alveolus development	5	16	31.25	0.0106785370075104	0.311871793150852	1	1	0.999962599350624	0.999962599350624	1
down	TNFSF11; ADRB2; IL7; RAC2; PTK2B; GPR55;	GO:0045453~bone resorption	6	23	26.0869565217391	0.0107765047678763	0.312591947824656	1	1	0.999962599350624	0.999962599350624	1
up	ATP6V1B1; SCNN1B; SCNN1G; CLCNKB; AMN; UGT1A7; ATP6V0A4; CLDN16;	GO:0007588~excretion	8	32	25	0.0110337036064017	0.580298853967681	1	1	0.99999999976568	0.99999999976568	1
up	WNT9B; MMP16; PRRX1; IRX5; SIX1; GRHL2; SIX2; SIX4;	GO:0048701~embryonic cranial skeleton morphogenesis	8	32	25	0.0110337036064017	0.580298853967681	1	1	0.99999999976568	0.99999999976568	1
up	SULT2B1; SFN; SFRP4; KDF1;	GO:0045606~positive regulation of epidermal cell differentiation	4	8	50	0.0110347656794749	0.580298853967681	1	1	0.99999999976568	0.99999999976568	1
up	SCNN1B; SCNN1G; AQP4; TRPV4;	GO:0050891~multicellular organismal water homeostasis	4	8	50	0.0110347656794749	0.580298853967681	1	1	0.99999999976568	0.99999999976568	1
down	IFNG; IL4; AZU1; IL10;	GO:0045348~positive regulation of MHC class II biosynthetic process	4	10	40	0.0113288551365207	0.324202941624995	1	1	0.999962599350624	0.999962599350624	1
down	PTPN6; FCRL3; TLR9; SLAMF8;	GO:0045577~regulation of B cell differentiation	4	10	40	0.0113288551365207	0.324202941624995	1	1	0.999962599350624	0.999962599350624	1
down	RGS14; BMP4; PTPN6; RGS2; INPP5K; CD300A; SPRY4; SPRY1;	GO:0043407~negative regulation of MAP kinase activity	8	39	20.5128205128205	0.0115103557344876	0.326300505781422	1	1	0.999962599350624	0.999962599350624	1
down	S1PR4; HTR2A; AVPR1A; P2RY12; NMUR1; GPR55; ARHGAP6;	GO:0007202~activation of phospholipase C activity	7	31	22.5806451612903	0.0115552008379444	0.326300505781422	1	1	0.999962599350624	0.999962599350624	1
down	PRSS2; AZU1; IL12B; CCR7; CXCL12; ADAM8; FUT7; APBB1IP; CHRD;	GO:0045785~positive regulation of cell adhesion	9	48	18.75	0.0123222390609036	0.340931698666089	1	1	0.999962599350624	0.999962599350624	1
down	HPX; EPB42; AHSP;	GO:0020027~hemoglobin metabolic process	3	5	60	0.0127129784446314	0.340931698666089	1	1	0.999962599350624	0.999962599350624	1
down	CNR2; CD300LF; CD84;	GO:0033004~negative regulation of mast cell activation	3	5	60	0.0127129784446314	0.340931698666089	1	1	0.999962599350624	0.999962599350624	1
down	TYROBP; OCSTAMP; DCSTAMP;	GO:0034241~positive regulation of macrophage fusion	3	5	60	0.0127129784446314	0.340931698666089	1	1	0.999962599350624	0.999962599350624	1
down	TOX; ID2; NKX2-3;	GO:0048541~Peyer's patch development	3	5	60	0.0127129784446314	0.340931698666089	1	1	0.999962599350624	0.999962599350624	1
down	RAB32; HPS1; TRAPPC6A;	GO:1903232~melanosome assembly	3	5	60	0.0127129784446314	0.340931698666089	1	1	0.999962599350624	0.999962599350624	1
up	RTL1; LEFTY2; WNT9B; GALR2; NOBOX; EYA4; IGF2; FGF1; HOXC6; HOXB1; PMCH; MYCNOS; MEOX2; TBX4; HLF; ODF4; TDRG1; SLC9C1; ANO1; TXNDC8; SPATA19; PLCZ1; EGFL6; FAT3; TWIST2; TCP11; PIWIL1; PRRX2; JPH2; AMN; MOV10L1; EBF3; FMN2; EHF; THEG; DKK4; NKX1-2; WIF1; ERBB4; CDH12; CDH11; FGFR3; CDH3; CDH6; CDH8; CDH15; CDH13; EGFR; ERBB3; MST1R; NTRK2; CDH10; SPINK6; EPHA6; CDH26; CDH1; ROS1; KDR; CDH18; SPINK5;	GO:0007275~multicellular organism development	60	513	11.6959064327485	0.0129775404260993	0.595847730028244	1	1	0.99999999976568	0.99999999976568	1
down	GZMA; PRF1; GZMH; GZMM; MMD;	GO:0019835~cytolysis	5	17	29.4117647058824	0.0130776303276379	0.346354134888496	1	1	0.999962599350624	0.999962599350624	1
down	ADAMTS13; NAALADL1; CPQ; ENPEP; LVRN;	GO:0043171~peptide catabolic process	5	17	29.4117647058824	0.0130776303276379	0.346354134888496	1	1	0.999962599350624	0.999962599350624	1
up	JUP; PKP2; PKP3;	GO:0002159~desmosome assembly	3	4	75	0.0131049645328635	0.595847730028244	1	1	0.99999999976568	0.99999999976568	1
up	SLC26A4; ANO1; SLC5A5;	GO:0015705~iodide transport	3	4	75	0.0131049645328635	0.595847730028244	1	1	0.99999999976568	0.99999999976568	1
up	CIDEA; APOA4; LY6D;	GO:0035634~response to stilbenoid	3	4	75	0.0131049645328635	0.595847730028244	1	1	0.99999999976568	0.99999999976568	1
up	COL11A1; COMP; SCX;	GO:0035989~tendon development	3	4	75	0.0131049645328635	0.595847730028244	1	1	0.99999999976568	0.99999999976568	1
up	KRT14; PKP1; PKP2;	GO:0045110~intermediate filament bundle assembly	3	4	75	0.0131049645328635	0.595847730028244	1	1	0.99999999976568	0.99999999976568	1
up	WNT9B; SIGLEC6; FGF18; CXCL10; THY1; INHA; CGB7; FGF5; PTHLH; FGFR3; GJB2; ADORA1; GDF5; GATA4; PCDH1; EFNB3; TFAP2C; FGF14; TBX5; BARX1; FGF21; GJB4; IL36G; TRHDE; CCL26; ADRB3; DRD2; DRD1; ADRA1D; FGFBP1; ADRA1B;	GO:0007267~cell-cell signaling	31	230	13.4782608695652	0.0131376481994466	0.595847730028244	1	1	0.99999999976568	0.99999999976568	1
up	CTAGE4; CTAGE9; CTAGE8; CTAGE3P; CTAGE6;	GO:0035459~vesicle cargo loading	5	14	35.7142857142857	0.0133221942954026	0.595847730028244	1	1	0.99999999976568	0.99999999976568	1
up	ALDH1A3; CYP27C1; SDR16C5; BCO1; RPE65;	GO:0042574~retinal metabolic process	5	14	35.7142857142857	0.0133221942954026	0.595847730028244	1	1	0.99999999976568	0.99999999976568	1
up	SNAI2; GLI2; PTHLH; GDF5; NKX3-2; EFEMP1;	GO:0032331~negative regulation of chondrocyte differentiation	6	20	30	0.0133299268462694	0.595847730028244	1	1	0.99999999976568	0.99999999976568	1
up	GABBR2; GABRR1; GABRA2; GABRA4; GABRA5; GABRA3; GABRE;	GO:0007214~gamma-aminobutyric acid signaling pathway	7	27	25.9259259259259	0.0145408156267528	0.64195008248479	1	1	0.99999999976568	0.99999999976568	1
down	LTF; CARD16; SIGIRR; LILRA2;	GO:0031665~negative regulation of lipopolysaccharide-mediated signaling pathway	4	11	36.3636363636364	0.0146486804316586	0.38320229055578	1	1	0.999962599350624	0.999962599350624	1
down	SASH3; IL7; YBX3; HLX;	GO:0046622~positive regulation of organ growth	4	11	36.3636363636364	0.0146486804316586	0.38320229055578	1	1	0.999962599350624	0.999962599350624	1
up	CYP2J2; CYP4F8; PTGIS; CYP2S1;	GO:0006690~icosanoid metabolic process	4	9	44.4444444444444	0.0149672121499126	0.652716471318139	1	1	0.99999999976568	0.99999999976568	1
down	CCL1; CCR2; CXCL12; AIF1; MOSPD2;	GO:0090026~positive regulation of monocyte chemotaxis	5	18	27.7777777777778	0.0158153338621	0.4111986804146	1	1	0.999962599350624	0.999962599350624	1
down	WNT1; BMP4; HOXA11; PGF; GPC3; ILK; DCHS1; WNT6;	GO:0001658~branching involved in ureteric bud morphogenesis	8	42	19.047619047619	0.0164954035681074	0.42628121705703	1	1	0.999962599350624	0.999962599350624	1
up	TACSTD2; SERPINB5; SIX1; HES5; SIX4;	GO:0050678~regulation of epithelial cell proliferation	5	15	33.3333333333333	0.0166430051829033	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
down	BIN1; CCL21; CSF3; CCR7; NCKAP1L; PTK2B; LMOD2; PYCARD; CDC42EP3;	GO:0030838~positive regulation of actin filament polymerization	9	51	17.6470588235294	0.0169627752863162	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
up	FOXE1; GLI2; FGF7; TGM3; TMEM79; FOXQ1; TP63;	GO:0031069~hair follicle morphogenesis	7	28	25	0.0169811954029985	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
down	CD3D; LCK; RHOH; DLL4; TBX21; CD3E; CD3G;	GO:0030217~T cell differentiation	7	34	20.5882352941176	0.0173226110098523	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	ADCY5; GLP2R; GCG; ARG1; PRKAR2B; PCK1;	GO:0071377~cellular response to glucagon stimulus	6	26	23.0769230769231	0.0173544969590343	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	ALOX5; LBP; SLAMF8;	GO:0002232~leukocyte chemotaxis involved in inflammatory response	3	6	50	0.0181373973517291	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	CD19; CD180; GAPT;	GO:0002322~B cell proliferation involved in immune response	3	6	50	0.0181373973517291	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	APOA2; IL10; LILRB1;	GO:0002740~negative regulation of cytokine secretion involved in immune response	3	6	50	0.0181373973517291	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	URAD; GMPR; TTR;	GO:0006144~purine nucleobase metabolic process	3	6	50	0.0181373973517291	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	DLL1; CDX1; CDX2;	GO:0014807~regulation of somitogenesis	3	6	50	0.0181373973517291	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	IL4; PRLR; PTK2B;	GO:0042976~activation of Janus kinase activity	3	6	50	0.0181373973517291	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	PF4; SPI1; IL10;	GO:0045347~negative regulation of MHC class II biosynthetic process	3	6	50	0.0181373973517291	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	CD80; HLX; CCL19;	GO:0045627~positive regulation of T-helper 1 cell differentiation	3	6	50	0.0181373973517291	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	IFNG; FCER2; PRF1;	GO:0051712~positive regulation of killing of cells of other organism	3	6	50	0.0181373973517291	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	IRF4; BATF; LY9;	GO:0072540~T-helper 17 cell lineage commitment	3	6	50	0.0181373973517291	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	CCL21; PRF1; CORO1A; CCL19;	GO:0001771~immunological synapse formation	4	12	33.3333333333333	0.0185231344112757	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	KCNE1B; KCNQ1; KCNE4; KCNE5;	GO:0098915~membrane repolarization during ventricular cardiac muscle cell action potential	4	12	33.3333333333333	0.0185231344112757	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	PTPRD; NTRK3; LRRTM1; LRFN1;	GO:0099151~regulation of postsynaptic density assembly	4	12	33.3333333333333	0.0185231344112757	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
up	TH; GLI2; PTN; ERBB3; EDNRA; RIPPLY3; HAND2; CXADR; IRX4; FOXF1; NFATC4; ERBB4; ARMC4; RBM20; OSR1; DNAH5; TBX5; FOXC2; PKP2; STRA6; FLRT3; HSPB7; PRICKLE4; SOX17; PDLIM3; POPDC3;	GO:0007507~heart development	26	190	13.6842105263158	0.0185644885133583	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
down	SLC4A1; SLC17A4; SLC17A3; SLC17A1; SLC17A7;	GO:0006820~anion transport	5	19	26.3157894736842	0.0189095402333675	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	HOXA11; SOX5; ACVRL1; ZBTB16; PKDCC;	GO:0032332~positive regulation of chondrocyte differentiation	5	19	26.3157894736842	0.0189095402333675	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	FFAR3; IL7; LBP; TLR9; TLR7;	GO:0032722~positive regulation of chemokine production	5	19	26.3157894736842	0.0189095402333675	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	IL12B; ERP29; DRD3; SRCIN1; SERGEF;	GO:0050709~negative regulation of protein secretion	5	19	26.3157894736842	0.0189095402333675	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
up	PATE4; SLURP1; LYPD6; LYPD6B;	GO:0099601~regulation of neurotransmitter receptor activity	4	10	40	0.0196804393605424	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	GALR2; GALR3; PMCH; NTRK2; NPW; MRAP2; STRA6;	GO:0007631~feeding behavior	7	29	24.1379310344828	0.0196966894725823	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	AKR1B15; PIR; PRODH; HR; AKR1B10; FMO6P; ALOX12B; CBR3; ALDH1L1; BBOX1; TM7SF2; CH25H; CYP1A1; CYP11A1; CYP2E1; LIPF; TH; GSTA1; SOD3; CYP2C9; CYP4B1; HPGD; TYRP1; MAOA; ACADL; ALDH3A1; FMO3; CYP2C19; ADH7; ALDH1A3; ALDH3B2; CYP4F8; CYP4A11; DHCR24; RPE65; PTGIS; CYP27C1; CYP4A22; TXNDC8; HEPHL1; FA2H; CYP4Z1; CYP4X1; CYP4Z2P; SDR16C5; FADS6; SDR9C7; GPX8; EGLN3; BCO1; CYP4F11; NOX4; DUOX1; CYP39A1; CYP2J2; CYP2F1; CYP2C18; CYP2W1; CYP2S1; CYP51A1;	GO:0055114~oxidation-reduction process	60	526	11.4068441064639	0.019712479687636	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	GABBR2; ADRA1D; ADRA1B;	GO:0150099~neuron-glial cell signaling	3	5	60	0.0197613378192931	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
down	IFNG; AZU1; AIF1; CX3CL1; TLR8; TLR7;	GO:0001774~microglial cell activation	6	27	22.2222222222222	0.0200503596640866	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	GNGT2; RCVRN; CABP4; UNC119; PLEKHB1; GPR88;	GO:0007602~phototransduction	6	27	22.2222222222222	0.0200503596640866	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	IFNG; FGR; IL10; CLEC6A; CLEC9A; RGCC;	GO:0050715~positive regulation of cytokine secretion	6	27	22.2222222222222	0.0200503596640866	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	HOXB5; HOXB8; HOXB6; HOXA5; HOXA6; HOXA7; HOXB9; HOXA9;	GO:0048704~embryonic skeletal system morphogenesis	8	44	18.1818181818182	0.0205816053917069	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
up	SULT2B1; CYP1A1; CYP2E1; CYP2C9; UGT1A1; CYP2C19; SULT4A1; UGT1A8; DHCR24;	GO:0008202~steroid metabolic process	9	44	20.4545454545455	0.0206134519914432	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	MATN3; COL4A1; DCN; COL11A1; CDH1; ELN; ITGB6; BGN; LAMA1; COL8A1; COL4A5; FBN2; KDR; SERPINB5; COMP; MFAP2; WNT3A; COL14A1; FOXF1; FOXF2; MFAP5; ADAMTSL2; EGFL6; SPINK5; COL15A1; MMP23B; MMP16; MMP28; POSTN; VIT;	GO:0030198~extracellular matrix organization	30	230	13.0434782608696	0.0208534630032866	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
down	LPL; ADRB2; ADRB1; YBX3; GMPR; PCSK1N; UCP2;	GO:0009409~response to cold	7	36	19.4444444444444	0.0221405681328116	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	SLIT2; EPHA7; LGR6; SEMA4D; SEMA3A; SEMA3D; SEMA4A;	GO:0050919~negative chemotaxis	7	36	19.4444444444444	0.0221405681328116	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	DLL1; GADD45G; TFF1; PTPN6; PGF; HHEX; HLX; COL19A1; INSC; RNF151; TMEM176B; PKDCC; MYO7B; TCF23; ZSCAN2; MORC1; TXNDC2; SLC22A16; UNC45B; NME8; ANKS4B; PSMA8; VSTM2A; MYCBPAP; GTSF1; TESC; EID2B; CFAP54; TSSK3; SPAG8; HEMGN; RBM38; SMOC1; BEX1; THSD7A; TLL2; LCK; FOXA2; ID2; NR1H4; ETV1; HEYL; NR1I2; CDX2; HNF4A; FOXA3; NKX3-1; CDX1; FGR; SPI1; ETV3L; FES; NKX2-3; SPIB; SLA;	GO:0030154~cell differentiation	55	572	9.61538461538462	0.0222651872368977	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	NCKAP1L; PARVG; RHOG; CYFIP2; RAC2;	GO:0030031~cell projection assembly	5	20	25	0.0223762594778744	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	NPRL2; MAP1LC3B; GABARAPL2; MAP1LC3B2;	GO:0006995~cellular response to nitrogen starvation	4	13	30.7692307692308	0.0229753063299303	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	EGF; ADRB2; PRLR; CHRNA3;	GO:0007171~activation of transmembrane receptor protein tyrosine kinase activity	4	13	30.7692307692308	0.0229753063299303	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	MEGF10; XKR8; RHOG; RAC2;	GO:0043652~engulfment of apoptotic cell	4	13	30.7692307692308	0.0229753063299303	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	IL7; CD27; NCKAP1L; PPP2R3C;	GO:0045579~positive regulation of B cell differentiation	4	13	30.7692307692308	0.0229753063299303	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	SKAP2; PRKCB; MS4A1; CXCR5; FCRL1; LAT2;	GO:0042113~B cell activation	6	28	21.4285714285714	0.0230168621350745	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	GNAI2; RCVRN; P2RX1; IL16; ORAI1; P2RY12;	GO:0051924~regulation of calcium ion transport	6	28	21.4285714285714	0.0230168621350745	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	PI15; EDIL3; VENTX; GADD45G; CSF3; ZGLP1; OSM; MMP11; HOXA10; HOXA9; HOXA11; HOXD13; ARHGDIB; FOXA3; TCL1A; TNFRSF17; ID2; CLC; NFATC3; HLX; NFE2; GFI1B; DPY19L2; SHISA2; ZSCAN2; MORC1; TXNDC2; SLC22A16; GPR65; NME8; MYCBPAP; TSSK3; NKX3-1; EBF4; HEMGN; PDGFD; PLEKHB1; DMBT1; TBX21; NOSIP; TLL2; NR1H4; NTRK3; CDH19; EPHA7; NR1I2; LDB2; LTK; FLT3; FGFR4;	GO:0007275~multicellular organism development	50	513	9.74658869395711	0.023130117470573	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
up	AMBP; SLPI; LPA; ANOS1; SERPINB3; SPINK7; ITIH5; WFDC13; WFDC5; WFDC12; CSTL1; FETUB; SERPINB13; SERPINI2; SERPINB7; SERPINB4; HRG; AHSG; SERPINB12; SERPINB5; SERPINB11;	GO:0010951~negative regulation of endopeptidase activity	21	148	14.1891891891892	0.0233460545613793	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
down	BMP4; SPI1; BATF;	GO:0002320~lymphoid progenitor cell differentiation	3	7	42.8571428571429	0.0246488613676255	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	CCL21; CCR7; CCL19;	GO:0002606~positive regulation of dendritic cell antigen processing and presentation	3	7	42.8571428571429	0.0246488613676255	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	HPX; TLR9; SASH3;	GO:0002639~positive regulation of immunoglobulin production	3	7	42.8571428571429	0.0246488613676255	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	SKAP1; PYCARD; SASH3;	GO:0002821~positive regulation of adaptive immune response	3	7	42.8571428571429	0.0246488613676255	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	GUK1; NME3; NME2P1;	GO:0006163~purine nucleotide metabolic process	3	7	42.8571428571429	0.0246488613676255	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	OAZ2; OAZ1; SMOX;	GO:0006596~polyamine biosynthetic process	3	7	42.8571428571429	0.0246488613676255	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	BPI; IL10; TLR9;	GO:0032717~negative regulation of interleukin-8 production	3	7	42.8571428571429	0.0246488613676255	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	RNASE2; RNASE3; DMBT1;	GO:0043152~induction of bacterial agglutination	3	7	42.8571428571429	0.0246488613676255	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	FCN1; FCN3; MEGF10;	GO:0043654~recognition of apoptotic cell	3	7	42.8571428571429	0.0246488613676255	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	IFRD1; EPHA7; FGF13;	GO:0048671~negative regulation of collateral sprouting	3	7	42.8571428571429	0.0246488613676255	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	NTRK3; TMEM108; CYFIP2;	GO:0051388~positive regulation of neurotrophin TRK receptor signaling pathway	3	7	42.8571428571429	0.0246488613676255	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	CACNA1G; SCN2B; SCN1B;	GO:0060371~regulation of atrial cardiac muscle cell membrane depolarization	3	7	42.8571428571429	0.0246488613676255	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	CX3CR1; CX3CL1; P2RY12;	GO:1904141~positive regulation of microglial cell migration	3	7	42.8571428571429	0.0246488613676255	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
down	DLL1; SPRY1; SKAP2; NEURL1; TFF1; REG1A; BMP4; IFITM1; OSM; GATA1; BMP5; IL10; PTPN6; AVPR2; SSTR2; SSTR3; ACVRL1; CD200; HNF4A; MXI1; CDKN2D; CCL23; BTG1; INSM1; ZBTB16; PTK2B; ZBTB49; IFNL1; RASSF5; RXFP2; HIST1H2AC; RERG; TESC; GML; NKX3-1; EIF2AK1; RGCC; DLL4; ATP8A2; SIRPG;	GO:0008285~negative regulation of cell population proliferation	40	396	10.1010101010101	0.0248106446662431	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
up	VIT; COL12A1; COL14A1; MATN3; VWA2;	GO:0003429~growth plate cartilage chondrocyte morphogenesis	5	17	29.4117647058824	0.0248287823524459	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
down	HP; SERPINA1; ORM1; LBP; ORM2; REG3A; SIGIRR;	GO:0006953~acute-phase response	7	37	18.9189189189189	0.0248661959788223	0.431225958257364	1	1	0.999962599350624	0.999962599350624	1
up	IRF6; KLK8; CDH13; SDR16C5;	GO:0043616~keratinocyte proliferation	4	11	36.3636363636364	0.0252109517863378	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	BMP7; FGF7; LAMA1; ESRP2;	GO:0060445~branching involved in salivary gland morphogenesis	4	11	36.3636363636364	0.0252109517863378	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
down	BMP4; HCLS1; GATA1; TAL1; SPI1; SLC25A38; TRIM10; AHSP;	GO:0030218~erythrocyte differentiation	8	46	17.3913043478261	0.025337932172689	0.435648962840104	1	1	0.999962599350624	0.999962599350624	1
down	SLIT2; PGF; AIF1; INPP5K; NCOA1; AVPR2; GPR150; AVPR1A;	GO:0032870~cellular response to hormone stimulus	8	46	17.3913043478261	0.025337932172689	0.435648962840104	1	1	0.999962599350624	0.999962599350624	1
down	SASH3; CD3E; HLA-E; CD40LG; FCER1G;	GO:0032753~positive regulation of interleukin-4 production	5	21	23.8095238095238	0.0262295083450694	0.442648968658274	1	1	0.999962599350624	0.999962599350624	1
down	TYROBP; IFNG; AZU1; CCR2; LBP;	GO:0042535~positive regulation of tumor necrosis factor biosynthetic process	5	21	23.8095238095238	0.0262295083450694	0.442648968658274	1	1	0.999962599350624	0.999962599350624	1
down	NCR3; IL18RAP; CD160; HLA-E; LAG3;	GO:0045954~positive regulation of natural killer cell mediated cytotoxicity	5	21	23.8095238095238	0.0262295083450694	0.442648968658274	1	1	0.999962599350624	0.999962599350624	1
down	P2RX1; KCNMB4; GPR88; SCN4A; SCN7A; CACNA1G;	GO:0019228~neuronal action potential	6	29	20.6896551724138	0.0262641156356809	0.442648968658274	1	1	0.999962599350624	0.999962599350624	1
down	PRL; IL10; IL10RB; IFNL1; CRLF3; ADIPOR1;	GO:0046427~positive regulation of receptor signaling pathway via JAK-STAT	6	29	20.6896551724138	0.0262641156356809	0.442648968658274	1	1	0.999962599350624	0.999962599350624	1
up	MAT1A; BHMT; BHMT2;	GO:0000096~sulfur amino acid metabolic process	3	6	50	0.0279438044704623	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	ADH1A; ADH4; ALDH3B2;	GO:0006066~alcohol metabolic process	3	6	50	0.0279438044704623	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	FUT3; PCDHA7; PCDHB6;	GO:0009988~cell-cell recognition	3	6	50	0.0279438044704623	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	CYP2E1; CYP2C9; CYP2C19;	GO:0016098~monoterpenoid metabolic process	3	6	50	0.0279438044704623	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	CYP2E1; UGT1A1; CYP2C19;	GO:0046483~heterocycle metabolic process	3	6	50	0.0279438044704623	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	TCF21; FOXF1; STRA6;	GO:0060426~lung vasculature development	3	6	50	0.0279438044704623	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	TBX18; FOXF1; SOX17;	GO:0072189~ureter development	3	6	50	0.0279438044704623	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	JUP; DSP; PKP2;	GO:0086073~bundle of His cell-Purkinje myocyte adhesion involved in cell communication	3	6	50	0.0279438044704623	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	GJB6; GJB2; GJB4;	GO:1990349~gap junction-mediated intercellular transport	3	6	50	0.0279438044704623	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
down	DLL1; MMP8; IL12B; FCGR2B;	GO:0032693~negative regulation of interleukin-10 production	4	14	28.5714285714286	0.0280228156047795	0.463136766429379	1	1	0.999962599350624	0.999962599350624	1
down	APOA2; MPO; CETP; PLA2G2A;	GO:0034374~low-density lipoprotein particle remodeling	4	14	28.5714285714286	0.0280228156047795	0.463136766429379	1	1	0.999962599350624	0.999962599350624	1
down	P2RY10; GPR171; P2RY13; P2RY12;	GO:0035589~G protein-coupled purinergic nucleotide receptor signaling pathway	4	14	28.5714285714286	0.0280228156047795	0.463136766429379	1	1	0.999962599350624	0.999962599350624	1
down	AZU1; IL16; PGF; CXCL12;	GO:0050930~induction of positive chemotaxis	4	14	28.5714285714286	0.0280228156047795	0.463136766429379	1	1	0.999962599350624	0.999962599350624	1
down	UPK3A; SCN7A; SLC12A3; SLC12A1;	GO:0055078~sodium ion homeostasis	4	14	28.5714285714286	0.0280228156047795	0.463136766429379	1	1	0.999962599350624	0.999962599350624	1
down	SNAI1; FAM107A; WNT11; F10; EGF; GNAI2; IL4; VIL1; FGR; CORO1A; AIF1; CCL7; INSM1; ILK; PTK2B; NTRK3; FAM89B; SEMA4D; LGR6; SUN2; CXCL12; SEMA3A; SEMA3D; PDGFD; SEMA4A;	GO:0030335~positive regulation of cell migration	25	226	11.0619469026549	0.0285336801930357	0.467952355165785	1	1	0.999962599350624	0.999962599350624	1
up	VEGFD; IGF2; FGF1; FGF5; PTN; FGF7; BTC; PROK1; GKN1;	GO:0051781~positive regulation of cell division	9	47	19.1489361702128	0.0286118182872861	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	BMP7; CSRP3; SGCG; GATA4; SGCD;	GO:0048738~cardiac muscle tissue development	5	18	27.7777777777778	0.0297403416362025	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	KISS1; RIMS1; NMU; CLSTN2; RIMS4;	GO:0050806~positive regulation of synaptic transmission	5	18	27.7777777777778	0.0297403416362025	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
down	SLIT2; BMP10; ACVRL1; SVBP; DLL4;	GO:0010596~negative regulation of endothelial cell migration	5	22	22.7272727272727	0.0304812309838047	0.490111736589688	1	1	0.999962599350624	0.999962599350624	1
down	AGR2; FASLG; HAP1; SHKBP1; PDE6H;	GO:0045742~positive regulation of epidermal growth factor receptor signaling pathway	5	22	22.7272727272727	0.0304812309838047	0.490111736589688	1	1	0.999962599350624	0.999962599350624	1
up	IL20RB; IL36A; IL36RN; IL1F10; IL36G; IL36B;	GO:0002437~inflammatory response to antigenic stimulus	6	25	24	0.0305682121870583	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
down	HOXB8; TMOD1; CXCL12; ID2; SEZ6; LGI4; SEZ6L; FOXA2;	GO:0008344~adult locomotory behavior	8	48	16.6666666666667	0.0308110651756607	0.490111736589688	1	1	0.999962599350624	0.999962599350624	1
down	CD3E; SSTR2; FCGR2B; SSTR3; HAP1; AIF1; NCOA1; NLGN4X;	GO:0021549~cerebellum development	8	48	16.6666666666667	0.0308110651756607	0.490111736589688	1	1	0.999962599350624	0.999962599350624	1
down	F2RL2; GPR65; P2RY10; DRD3; F2RL3; GPR174; GPR55;	GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway	7	39	17.9487179487179	0.0309873001623894	0.490111736589688	1	1	0.999962599350624	0.999962599350624	1
up	CASQ2; KRT19; SYNPO2L; MYOZ1; SIX4; MYOM3; CSRP3; TNNT2;	GO:0045214~sarcomere organization	8	40	20	0.031216291832897	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	SOX1; PITX3; SHROOM2; LCTL;	GO:0002089~lens morphogenesis in camera-type eye	4	12	33.3333333333333	0.0315845762664284	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	ADH1B; ADH1A; ADH4; ADH7;	GO:0006069~ethanol oxidation	4	12	33.3333333333333	0.0315845762664284	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	CHRNB4; CNN1; KCNB2; CHRM2;	GO:0006940~regulation of smooth muscle contraction	4	12	33.3333333333333	0.0315845762664284	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
down	CCL21; CCR7; CCL19;	GO:0001768~establishment of T cell polarity	3	8	37.5	0.0322480834584937	0.490111736589688	1	1	0.999962599350624	0.999962599350624	1
down	ADCY5; P2RY12; GNAI2;	GO:0001973~G protein-coupled adenosine receptor signaling pathway	3	8	37.5	0.0322480834584937	0.490111736589688	1	1	0.999962599350624	0.999962599350624	1
down	MS4A1; ORAI1; ORAI3;	GO:0002115~store-operated calcium entry	3	8	37.5	0.0322480834584937	0.490111736589688	1	1	0.999962599350624	0.999962599350624	1
down	SLC17A3; SLC17A1; SLC17A7;	GO:0006817~phosphate ion transport	3	8	37.5	0.0322480834584937	0.490111736589688	1	1	0.999962599350624	0.999962599350624	1
down	FOLR2; FOLR3; SLC19A1;	GO:0015884~folic acid transport	3	8	37.5	0.0322480834584937	0.490111736589688	1	1	0.999962599350624	0.999962599350624	1
down	ZG16; IL18RAP; LILRA2;	GO:0032635~interleukin-6 production	3	8	37.5	0.0322480834584937	0.490111736589688	1	1	0.999962599350624	0.999962599350624	1
down	CCL21; CCR7; CCL19;	GO:0034695~response to prostaglandin E	3	8	37.5	0.0322480834584937	0.490111736589688	1	1	0.999962599350624	0.999962599350624	1
down	IL4; IL10; LILRB1;	GO:0042536~negative regulation of tumor necrosis factor biosynthetic process	3	8	37.5	0.0322480834584937	0.490111736589688	1	1	0.999962599350624	0.999962599350624	1
down	TLR9; TLR8; TLR7;	GO:0045359~positive regulation of interferon-beta biosynthetic process	3	8	37.5	0.0322480834584937	0.490111736589688	1	1	0.999962599350624	0.999962599350624	1
down	PF4; CAMP; DEFA5;	GO:0051873~killing by host of symbiont cells	3	8	37.5	0.0322480834584937	0.490111736589688	1	1	0.999962599350624	0.999962599350624	1
down	ITGB7; GPR15; CCR6;	GO:0072678~T cell migration	3	8	37.5	0.0322480834584937	0.490111736589688	1	1	0.999962599350624	0.999962599350624	1
down	ELANE; CCR2; FUT7;	GO:1903238~positive regulation of leukocyte tethering or rolling	3	8	37.5	0.0322480834584937	0.490111736589688	1	1	0.999962599350624	0.999962599350624	1
down	ADRB2; RELN; ARC;	GO:2000969~positive regulation of AMPA receptor activity	3	8	37.5	0.0322480834584937	0.490111736589688	1	1	0.999962599350624	0.999962599350624	1
down	RGS16; ARHGAP6; RGS14; RGS10; WNT11; ADRB1; CHN1; RGS2; ARHGAP25; RGS6; ARHGDIB; NCKAP1L; NPRL3; GIT2; ACAP1; ARHGAP44; ARHGAP15; RINL; TAGAP; NPRL2; SEMA4D; SIPA1; CCL19; ARHGAP9; RGS18; CCL21; CCL7; CCL8; CX3CL1; XCL1; XCL2; CCL1; CCL23;	GO:0043547~positive regulation of GTPase activity	33	322	10.2484472049689	0.0327956729039983	0.490111736589688	1	1	0.999962599350624	0.999962599350624	1
up	FXYD1; TH; CHRM2; DES; TNNT2; CYP2J2; HSPB7;	GO:0008016~regulation of heart contraction	7	33	21.2121212121212	0.0335707170127473	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
down	LTF; BTNL10; BTNL3; HHLA2; BTN1A1; BTNL8;	GO:0001817~regulation of cytokine production	6	31	19.3548387096774	0.0336364222838443	0.490111736589688	1	1	0.999962599350624	0.999962599350624	1
down	PIAS1; IFNG; PRLR; CCR2; IFNAR2; IFNL1;	GO:0007259~receptor signaling pathway via JAK-STAT	6	31	19.3548387096774	0.0336364222838443	0.490111736589688	1	1	0.999962599350624	0.999962599350624	1
down	FOXO3; GATA1; TAL1; NCKAP1L; ID2; FAM210B;	GO:0045648~positive regulation of erythrocyte differentiation	6	31	19.3548387096774	0.0336364222838443	0.490111736589688	1	1	0.999962599350624	0.999962599350624	1
down	XCL1; NR1H4; TBX21; VSIG4;	GO:0032703~negative regulation of interleukin-2 production	4	15	26.6666666666667	0.03367794062401	0.490111736589688	1	1	0.999962599350624	0.999962599350624	1
down	CCL21; PTPN6; NCKAP1L; P2RY12;	GO:0033630~positive regulation of cell adhesion mediated by integrin	4	15	26.6666666666667	0.03367794062401	0.490111736589688	1	1	0.999962599350624	0.999962599350624	1
down	NLRP6; GPS2; IRF4; TLR9;	GO:0034122~negative regulation of toll-like receptor signaling pathway	4	15	26.6666666666667	0.03367794062401	0.490111736589688	1	1	0.999962599350624	0.999962599350624	1
down	TESPA1; LCK; CCR7; TRAT1;	GO:0050862~positive regulation of T cell receptor signaling pathway	4	15	26.6666666666667	0.03367794062401	0.490111736589688	1	1	0.999962599350624	0.999962599350624	1
down	RBP4; HOXA10; HOXA9; HOXA11;	GO:0060065~uterus development	4	15	26.6666666666667	0.03367794062401	0.490111736589688	1	1	0.999962599350624	0.999962599350624	1
down	BMP4; HOXA5; RSPO2; HHIP;	GO:0060441~epithelial tube branching involved in lung morphogenesis	4	15	26.6666666666667	0.03367794062401	0.490111736589688	1	1	0.999962599350624	0.999962599350624	1
down	HLA-G; ALOX5AP; SCARA5; ITLN1;	GO:0070207~protein homotrimerization	4	15	26.6666666666667	0.03367794062401	0.490111736589688	1	1	0.999962599350624	0.999962599350624	1
down	KCNQ1; KCNE4; KCNE1B; KCNE5;	GO:0097623~potassium ion export across plasma membrane	4	15	26.6666666666667	0.03367794062401	0.490111736589688	1	1	0.999962599350624	0.999962599350624	1
down	ARC; LILRB2; PAIP2; CYP46A1;	GO:1900271~regulation of long-term synaptic potentiation	4	15	26.6666666666667	0.03367794062401	0.490111736589688	1	1	0.999962599350624	0.999962599350624	1
down	SNAI1; CXCL12; CDKN2D; BCL2L1;	GO:1902230~negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage	4	15	26.6666666666667	0.03367794062401	0.490111736589688	1	1	0.999962599350624	0.999962599350624	1
down	CCL21; CXCL12; AIF1; PYCARD;	GO:2000406~positive regulation of T cell migration	4	15	26.6666666666667	0.03367794062401	0.490111736589688	1	1	0.999962599350624	0.999962599350624	1
down	ADCY5; ADRB2; ADRB1; AVPR2; VIPR2; LGR5; RXFP2;	GO:0007190~activation of adenylate cyclase activity	7	40	17.5	0.034395765437284	0.494573346692794	1	1	0.999962599350624	0.999962599350624	1
up	CHRNB4; RIMS1; CAMK2A; SNCAIP; CPLX1;	GO:0046928~regulation of neurotransmitter secretion	5	19	26.3157894736842	0.035221942409794	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	NPPB; AGTR1; P2RY1; FOXC2; ACE2;	GO:0097746~regulation of blood vessel diameter	5	19	26.3157894736842	0.035221942409794	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
down	FFAR3; ADCY5; GNAI2; SSTR2; OXER1; RXFP2; P2RY12; MARCO; PTGDR2;	GO:0007193~adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway	9	59	15.2542372881356	0.0353685746900869	0.494573346692794	1	1	0.999962599350624	0.999962599350624	1
up	CYP1A1; CYP2E1; CYP4A22;	GO:0002933~lipid hydroxylation	3	7	42.8571428571429	0.0376430062169669	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	TH; DRD1; NHLH2;	GO:0007617~mating behavior	3	7	42.8571428571429	0.0376430062169669	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	CYP1A1; UGT1A7; UGT1A8;	GO:0009804~coumarin metabolic process	3	7	42.8571428571429	0.0376430062169669	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	HTR1B; SLC6A1; ADORA1;	GO:0032229~negative regulation of synaptic transmission, GABAergic	3	7	42.8571428571429	0.0376430062169669	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	CA2; AGTR1; CAMK2A;	GO:0038166~angiotensin-activated signaling pathway	3	7	42.8571428571429	0.0376430062169669	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	AMBP; UGT1A1; UGT1A4;	GO:0042167~heme catabolic process	3	7	42.8571428571429	0.0376430062169669	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	SPINK6; SPINK5; ANXA8L1;	GO:1900004~negative regulation of serine-type endopeptidase activity	3	7	42.8571428571429	0.0376430062169669	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	PTN; RBM24; TACSTD2;	GO:2000738~positive regulation of stem cell differentiation	3	7	42.8571428571429	0.0376430062169669	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
down	UBB; MYD88; TLR9; TLR8; TLR7; LY96;	GO:0002755~MyD88-dependent toll-like receptor signaling pathway	6	32	18.75	0.0377766513048355	0.494573346692794	1	1	0.999962599350624	0.999962599350624	1
down	IL4; IL7; NCKAP1L; FCRL3; TLR9; SASH3; BST1;	GO:0030890~positive regulation of B cell proliferation	7	41	17.0731707317073	0.0380438460044704	0.494573346692794	1	1	0.999962599350624	0.999962599350624	1
up	TFAP2B; SIX1; NR2F2; NR2F1; EYA4; WIF1; SIX4; SIX2; TFAP2C;	GO:0048856~anatomical structure development	9	50	18	0.0385641500570955	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	FGF7; CDH3; TGM1; TP63;	GO:0010838~positive regulation of keratinocyte proliferation	4	13	30.7692307692308	0.0388168296030773	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	DRD2; DRD1; GRIN2A; SNCAIP;	GO:0042417~dopamine metabolic process	4	13	30.7692307692308	0.0388168296030773	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	GJA5; GATA4; TBX5; HEY2;	GO:0060413~atrial septum morphogenesis	4	13	30.7692307692308	0.0388168296030773	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	CNTN5; WNT3A; NLGN1; NLGN4Y;	GO:0099054~presynapse assembly	4	13	30.7692307692308	0.0388168296030773	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
down	BMP4; GPC3; CDX1; CDX2;	GO:0009948~anterior/posterior axis specification	4	16	25	0.0399478200960603	0.5013837273145	1	1	0.999962599350624	0.999962599350624	1
down	SLFN14; ERN2; DEDD2; EXOSC5;	GO:0016075~rRNA catabolic process	4	16	25	0.0399478200960603	0.5013837273145	1	1	0.999962599350624	0.999962599350624	1
down	CACNA1G; SCN2B; SCN1B; SCN4B;	GO:0086002~cardiac muscle cell action potential involved in contraction	4	16	25	0.0399478200960603	0.5013837273145	1	1	0.999962599350624	0.999962599350624	1
down	BMP5; ADIPOR1; SDHAF2; MAD2L2; FOXA2;	GO:0010719~negative regulation of epithelial to mesenchymal transition	5	24	20.8333333333333	0.0402172371461746	0.5013837273145	1	1	0.999962599350624	0.999962599350624	1
down	PPBP; SLC2A4; SLC5A2; SLC5A9; SLC45A1;	GO:1904659~glucose transmembrane transport	5	24	20.8333333333333	0.0402172371461746	0.5013837273145	1	1	0.999962599350624	0.999962599350624	1
down	DLL1; MFNG; PTK2B;	GO:0002315~marginal zone B cell differentiation	3	9	33.3333333333333	0.0409196850622529	0.5013837273145	1	1	0.999962599350624	0.999962599350624	1
down	AVPR2; NFE2; P2RY12;	GO:0007599~hemostasis	3	9	33.3333333333333	0.0409196850622529	0.5013837273145	1	1	0.999962599350624	0.999962599350624	1
down	CSF3; SPI1; CEBPE;	GO:0030851~granulocyte differentiation	3	9	33.3333333333333	0.0409196850622529	0.5013837273145	1	1	0.999962599350624	0.999962599350624	1
down	FES; RAC2; UNC13D;	GO:0043304~regulation of mast cell degranulation	3	9	33.3333333333333	0.0409196850622529	0.5013837273145	1	1	0.999962599350624	0.999962599350624	1
down	FXN; GLRX5; ISCA2;	GO:0044281~small molecule metabolic process	3	9	33.3333333333333	0.0409196850622529	0.5013837273145	1	1	0.999962599350624	0.999962599350624	1
down	IGHD; ORM1; ORM2;	GO:0050716~positive regulation of interleukin-1 secretion	3	9	33.3333333333333	0.0409196850622529	0.5013837273145	1	1	0.999962599350624	0.999962599350624	1
down	TYROBP; IFNG; AZU1;	GO:0050725~positive regulation of interleukin-1 beta biosynthetic process	3	9	33.3333333333333	0.0409196850622529	0.5013837273145	1	1	0.999962599350624	0.999962599350624	1
down	WNT11; HOXA5; FGF9;	GO:0060484~lung-associated mesenchyme development	3	9	33.3333333333333	0.0409196850622529	0.5013837273145	1	1	0.999962599350624	0.999962599350624	1
down	F2RL2; GP1BA; F2RL3;	GO:0070493~thrombin-activated receptor signaling pathway	3	9	33.3333333333333	0.0409196850622529	0.5013837273145	1	1	0.999962599350624	0.999962599350624	1
down	FOXO3; ID2; TRIM71;	GO:2000177~regulation of neural precursor cell proliferation	3	9	33.3333333333333	0.0409196850622529	0.5013837273145	1	1	0.999962599350624	0.999962599350624	1
down	LILRA5; IL4; PYCARD;	GO:2001181~positive regulation of interleukin-10 secretion	3	9	33.3333333333333	0.0409196850622529	0.5013837273145	1	1	0.999962599350624	0.999962599350624	1
up	PRRX1; NKX3-2; SIX1; OSR1; SIX2;	GO:0042474~middle ear morphogenesis	5	20	25	0.0412865382936684	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
down	CA1; SLC4A1; CA4; CA6; CA7; HBA1; RHAG;	GO:0015701~bicarbonate transport	7	42	16.6666666666667	0.0419365146670673	0.510906567258214	1	1	0.999962599350624	0.999962599350624	1
down	GPR55; GPR174; GPR65; F2RL2; F2RL3; P2RY10;	GO:0035025~positive regulation of Rho protein signal transduction	6	33	18.1818181818182	0.0422279084251188	0.512990887534777	1	1	0.999962599350624	0.999962599350624	1
up	LRAT; ZIC2; EYA4; TH; TACSTD2; RBP3; GNAT1; COL11A1; CDH3; GLRB; GPR143; RP1; IRX5; POU6F2; EFEMP1; CNGA3; RPE65; IMPG1; NXNL2; LCTL; RD3; TRPM1; RIMS1; MYO3A; CABP1; VAX2;	GO:0007601~visual perception	26	207	12.56038647343	0.0422292015313983	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	ABCC9; KCNJ8; KCNK9; ATP12A; ATP4B; ATP4A; KCNJ18; KCNJ16;	GO:1990573~potassium ion import across plasma membrane	8	43	18.6046511627907	0.0429243337557963	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
down	F2RL2; WNT1; CCR2; CX3CR1; HHEX; HOXB13; F2RL3; LYVE1; FGFR1OP2;	GO:0009611~response to wounding	9	62	14.5161290322581	0.0448767509967131	0.531695157681801	1	1	0.999962599350624	0.999962599350624	1
down	RNASET2; RNASE2; RNASE3; RNASE6; ISG20;	GO:0006401~RNA catabolic process	5	25	20	0.0457147262679631	0.531695157681801	1	1	0.999962599350624	0.999962599350624	1
down	INSM1; ID2; CRLF3; RGCC; RNF112;	GO:0071158~positive regulation of cell cycle arrest	5	25	20	0.0457147262679631	0.531695157681801	1	1	0.999962599350624	0.999962599350624	1
down	ARG1; CORO1A; XCL1; ADAMTS13; DCSTAMP;	GO:0071353~cellular response to interleukin-4	5	25	20	0.0457147262679631	0.531695157681801	1	1	0.999962599350624	0.999962599350624	1
up	COBL; CYP1A1; CCNB1; CLDN18; FOXF1; LGR4;	GO:0048565~digestive tract development	6	28	21.4285714285714	0.0458140066557711	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
down	ADAMTS3; MMP1; PRSS2; MMP8; MMP11; COL19A1; MMP17;	GO:0030574~collagen catabolic process	7	43	16.2790697674419	0.046078090892371	0.531695157681801	1	1	0.999962599350624	0.999962599350624	1
up	ZBTB7C; SNAI2; ADIG; KLF5; MEDAG; SFRP1; LMO3; CDS1; WIF1;	GO:0045600~positive regulation of fat cell differentiation	9	52	17.3076923076923	0.0463694137790444	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
down	TOX; CXCR5; LTB; NKX2-3;	GO:0048535~lymph node development	4	17	23.5294117647059	0.0468347102345146	0.531695157681801	1	1	0.999962599350624	0.999962599350624	1
down	SLC4A1; GATA1; NCKAP1L; RHAG;	GO:0048821~erythrocyte development	4	17	23.5294117647059	0.0468347102345146	0.531695157681801	1	1	0.999962599350624	0.999962599350624	1
down	CCL21; AIF1; CCL19; P2RY12;	GO:0050921~positive regulation of chemotaxis	4	17	23.5294117647059	0.0468347102345146	0.531695157681801	1	1	0.999962599350624	0.999962599350624	1
down	BMP10; BMP4; SOX5; ZBTB16;	GO:0061036~positive regulation of cartilage development	4	17	23.5294117647059	0.0468347102345146	0.531695157681801	1	1	0.999962599350624	0.999962599350624	1
up	FUT3; MGAT2; ST6GALNAC5; B3GALT5;	GO:0009312~oligosaccharide biosynthetic process	4	14	28.5714285714286	0.0469134631823872	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	SNAI2; SFN; SLURP1; KDF1;	GO:0010839~negative regulation of keratinocyte proliferation	4	14	28.5714285714286	0.0469134631823872	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	DRD2; NPPB; BTC; TFAP2B;	GO:0035810~positive regulation of urine volume	4	14	28.5714285714286	0.0469134631823872	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	SCNN1B; SCNN1G; CYP4A11; TFAP2B;	GO:0055078~sodium ion homeostasis	4	14	28.5714285714286	0.0469134631823872	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	SOX15; GJB5; NR2F2; MDFI;	GO:0060707~trophoblast giant cell differentiation	4	14	28.5714285714286	0.0469134631823872	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	VEGFD; PITX3; FOXA1; SFRP1; DMRTA2;	GO:0071542~dopaminergic neuron differentiation	5	21	23.8095238095238	0.0479428743525776	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	DRD1; ADRA1D; ADRA1B; DRD2; ADRB3;	GO:0071880~adenylate cyclase-activating adrenergic receptor signaling pathway	5	21	23.8095238095238	0.0479428743525776	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	CACNG7; NLGN1; SHANK1; SHANK2; SHISA6;	GO:2000311~regulation of AMPA receptor activity	5	21	23.8095238095238	0.0479428743525776	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	FGF18; FUT2; ANGPT1;	GO:0001936~regulation of endothelial cell proliferation	3	8	37.5	0.0488207133520711	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	SPINK5; OVOL1; OVOL2;	GO:0009913~epidermal cell differentiation	3	8	37.5	0.0488207133520711	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	SFRP1; MDFI; VAX2;	GO:0009950~dorsal/ventral axis specification	3	8	37.5	0.0488207133520711	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	APOA4; AADAC; FGF21;	GO:0010898~positive regulation of triglyceride catabolic process	3	8	37.5	0.0488207133520711	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	GJB6; GJB2; GJA5;	GO:0016264~gap junction assembly	3	8	37.5	0.0488207133520711	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	ATP6V1B1; GJB4; SHANK1;	GO:0042048~olfactory behavior	3	8	37.5	0.0488207133520711	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	BMPR1B; EGFR; NHLH2;	GO:0042698~ovulation cycle	3	8	37.5	0.0488207133520711	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	NGF; SOX2; TP63;	GO:0043281~regulation of cysteine-type endopeptidase activity involved in apoptotic process	3	8	37.5	0.0488207133520711	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	RP1; NTRK2; TRPM1;	GO:0046548~retinal rod cell development	3	8	37.5	0.0488207133520711	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	HOXB1; FOXA1; DLX5;	GO:0048646~anatomical structure formation involved in morphogenesis	3	8	37.5	0.0488207133520711	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	SIX1; OSR1; SIX4;	GO:0072075~metanephric mesenchyme development	3	8	37.5	0.0488207133520711	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
up	FOXE1; TP63; COLEC10;	GO:1904888~cranial skeletal system development	3	8	37.5	0.0488207133520711	0.698552476812819	1	1	0.99999999976568	0.99999999976568	1
